Tech
In reversal, American Cancer Society urges routine prostate cancer screening
Publication: Ars Technica
Author: Beth Mole
Source published: 12/11/2026, 22:59:51 UTC
Briefing created: 13/11/2026, 02:44:03 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 13/11/2026, 02:43:23 UTC.
Briefings
The American Cancer Society updated its prostate cancer screening guidelines, shifting recommendations for men aged 50 to 69 to routine PSA testing every two years. Men at high risk due to family history or race are advised to start at age 45, with Black men receiving yearly testing regardless of relative history. Non-Black men with a close relative diagnosed before age 65 also start at 45 but face a two-year interval, while those with a relative diagnosed at or after age 65 follow the standard two-year schedule.
Key points
- Men aged 50 to 69 at average risk should receive a PSA test every two years.
- Black men must get a PSA test every year starting at age 45.
Context
The American Cancer Society released new guidelines on Thursday, shifting from a one-time screening approach to routine biennial testing for average-risk men. This update aims to balance early detection benefits with the potential harms of over-screening, particularly for men with higher cancer rates in specific demographic groups.
Limitations
Guidelines are based on current evidence and expert consensus, but long-term outcomes and cost-effectiveness data are not yet fully established. The study period is limited to the time of the guideline release, and future clinical trials may refine these recommendations.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 13/11/2026, 02:44:03 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeid3hysrs2z7z4lvy66zh33bnnagxczdnklhi4mfxcpugwzfiaq55m